Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
For breast cancer patients receiving chemotherapy regimens, the use of a validated emesis
(nausea and vomiting) risk calculator will provide superior anti-emetic (nausea and vomiting)
control compared with "standard" anti-emetic regimen. The risk calculator has the potential
to provide more individualized anti-emetic regimen by decreasing the use of toxic/costly
anti-emetics in patients at low risk and possibly more importantly enhancing the appropriate
anti-emetic regimen in patients at high risk.